ANIP - ANI Pharmaceuticals Q1 2022 Earnings Preview
ANI Pharmaceuticals (NASDAQ:ANIP) is scheduled to announce Q1 earnings results on Tuesday, May 10th, before market open. The consensus EPS Estimate is $0.09 (-91.3% Y/Y) and the consensus Revenue Estimate is $65.03M (+19.3% Y/Y). Over the last 2 years, ANIP has beaten EPS estimates 63% of the time and has beaten revenue estimates 88% of the time. Over the last 3 months, EPS estimates have seen 0 upward revisions and 2 downward. Revenue estimates have seen 1 upward revision and 1 downward.
For further details see:
ANI Pharmaceuticals Q1 2022 Earnings Preview